Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Com Stk Usd0.01 [Di] (MXCT.LN)

Com Stk Usd0.01 [Di] (MXCT.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs

MXCN.LN : 680.000 (unch)
MXCT.LN : 330.000 (-2.94%)
MXCT : 4.11 (-0.72%)
MaxCyte to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025, and Participate in Upcoming Investor Conference

MXCN.LN : 680.000 (unch)
MXCT.LN : 330.000 (-2.94%)
MXCT : 4.11 (-0.72%)
MaxCyte® Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments

MXCN.LN : 680.000 (unch)
MXCT.LN : 330.000 (-2.94%)
MXCT : 4.11 (-0.72%)
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results

MXCN.LN : 680.000 (unch)
MXCT.LN : 330.000 (-2.94%)
MXCT : 4.11 (-0.72%)
MaxCyte Announces Retirement of Board Member Art Mandell

MXCN.LN : 680.000 (unch)
MXCT.LN : 330.000 (-2.94%)
MXCT : 4.11 (-0.72%)
MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance

MXCN.LN : 680.000 (unch)
MXCT.LN : 330.000 (-2.94%)
MXCT : 4.11 (-0.72%)
MaxCyte Celebrates 25 Years of Innovation Driving Cell Engineering-Based Therapeutics

MXCN.LN : 680.000 (unch)
MXCT.LN : 330.000 (-2.94%)
MXCT : 4.11 (-0.72%)
MaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 Guidance

MXCN.LN : 680.000 (unch)
MXCT.LN : 330.000 (-2.94%)
MXCT : 4.11 (-0.72%)
MaxCyte to Participate in Two Upcoming Investor Conferences

MXCN.LN : 680.000 (unch)
MXCT.LN : 330.000 (-2.94%)
MXCT : 4.11 (-0.72%)
MaxCyte Appoints Cynthia Collins to its Board of Directors

PSTX : 9.50 (-0.63%)
MXCN.LN : 680.000 (unch)
DMTKQ : 0.0001 (unch)
MXCT.LN : 330.000 (-2.94%)
MXCT : 4.11 (-0.72%)
CERT : 13.57 (-2.09%)

Barchart Exclusives

Viant Technology - Update
Summary Viant Technology (DSP) gained 18% since last featured on 12/9 and 17.20% since Trend Seeker's buy signal on 1/24, showing strong momentum. The company offers advanced advertising solutions, including AI Bid Optimizer and Viant Data Platform, targeting programmatic advertising purchasers and agencies. Barchart's technical indicators show 100% buy signals,... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar